AQST (Aquestive Therapeutics) Short-Term Debt to Capital

Corporate company logo of Aquestive Therapeutics (AQST)

Aquestive Therapeutics specializes in creating innovative drug delivery systems, yet faces threats of underfunding and regulatory barriers. The business relies on unique soluble films, expanding their application from epilepsy therapy to allergy relief. This chart demonstrates the 0.00 metric, while the company actively implements its developments through strategic alliances to improve treatment efficacy.

Ratio of Short-Term Indebtedness to Capital: Aquestive Pharma (AQST) for 07/04/2022 - 11/01/2026
Brand item of Aquestive Therapeutics Inc

To minimize fundamental risks, investors select low-leverage assets where the ratio of liabilities due within one year to equity confirms liquidity. This calculation reveals a company's dependence on short-term borrowing, which is critical for Aquestive Therapeutics (AQST) when paying external CRO partners; therefore, the short-term debt-to-equity chart serves as an indicator of financial stability in the face of potential volatility.

Competitors of Aquestive Therapeutics (AQST)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EXOZ (eXoZymes)|Short-Term Debt to Capital Oramed ORMP|ENTX - Short-Term Debt to Equity|Short-Term Indebtedness to Equity MindWalk Therapeutics (HYFT)|ABVC (ABVC BioPharma) - Short-Term Debt to Equity Ratio|cumberlandpharma.com (CPIX) - Short-Term Debt to Capital|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|Current Liabilities to Capital FibroGen Inc FGEN|Short-Term Debt to Equity Telomir Pharma (TELO)|Short-Term Debt to Capital Coefficient ranitherapeutics.com|Synergy CHC - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio RLYB (Rallybio Corp)|Lexaria - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Pulmatrix Inc PULM|PTHL (ftzy.com.cn) - Short-Term Debt to Equity Ratio|APM (Aptorum Group) - Short-Term Debt to Equity|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital impactbiomedinc.com IBO|Short-Term Debt to Equity Ratio TNFA (TNF Pharmaceuticals)|YCBD (cbdmd.com) - Ratio of Short-Term Indebtedness to Capital|PainReform Limited - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CYTO (Altamira Therapeutics Ltd)|Lipella Pharmaceuticals - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital OPTN (optinose.com)|PIRS: Short-Term Debt to Capital|Current Liabilities to Capital Procaps Group (PROC)|Short-Term Debt to Equity Petros|QLI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital tffpharma.com (TFFP)